A synthetic peptide for use as a blocking control in assays to test for specificity of MAPK13 antibody, Alternative Names: MAPK13 control peptide, MAPK13 antibody Blocking Peptide, Anti-MAPK13 Blocking Peptide, mitogen-activated protein kinase 13 Blocking Peptide, MGC99536 Blocking Peptide, PRKM13 Blocking Peptide, SAPK4 Blocking Peptide, p38delta Blocking Peptide, MAPK13, MAPK-13, MAPK 13, MAPK-13 Blocking Peptide, MAPK 13 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MAPK13
(Mitogen-Activated Protein Kinase 13 (MAPK13))
Hintergrund
The protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is closely related to p38 MAP kinase, both of which can be activated by proinflammatory cytokines and cellular stress. MAP kinase kinases 3, and 6 can phosphorylate and activate this kinase. Transcription factor ATF2, and microtubule dynamics regulator stathmin have been shown to be the substrates of this kinase.